Jeena Sikho Lifecare is currently trading at Rs. 562.45, up by 1.70 points or 0.30% from its previous closing of Rs. 560.75 on the BSE.
The scrip opened at Rs. 558.15 and has touched a high and low of Rs. 574.55 and Rs. 554.50 respectively. So far 14725 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 850.00 on 17-Sep-2025 and a 52 week low of Rs. 491.95 on 01-Jun-2026.
Last one week high and low of the scrip stood at Rs. 588.00 and Rs. 554.50 respectively. The current market cap of the company is Rs. 7041.01 crore.
The promoters holding in the company stood at 63.62%, while Institutions and Non-Institutions held 5.14% and 31.23% respectively.
Jeena Sikho Lifecare is planning to establish a new Ayurvedic, Naturopathy and Panchkarma Hospital facility at Kalyani, District Nadia, West Bengal, as part of the company's expansion strategy. Spanning an estimated operational area of around 13,000 square feet, the upcoming hospital will house a capacity of over 60 beds.
The project requires an investment of around Rs 1.30 crore, which will be financed through the company's internal finance (owned funds). The facility is scheduled to commence operations by October 2026.
Jeena Sikho Lifecare is a developing health care services providers in India. The company has portfolio of over a wide range of Ayurvedic products. The company also conducts various health checkup camps, yoga sessions to make people aware of their health problem.
| Company Name | CMP |
|---|---|
| Redington | 262.10 |
| Amrapali Industries | 33.57 |
| Adani Enterprises | 3010.45 |
| Rashi Peripheral | 761.25 |
| PDS | 355.40 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: